64 related articles for article (PubMed ID: 1658886)
1. Species differences in alpha 2-adrenergic regulation of platelet adenylate cyclase.
Slotkin TA; McCook EC; Nemeroff CB; Seidler FJ
Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):259-71. PubMed ID: 1658886
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Ns-stimulated human platelet adenylate cyclase by forskolin.
Watanabe Y; Jakobs KH
Mol Pharmacol; 1986 Mar; 29(3):258-63. PubMed ID: 3005833
[TBL] [Abstract][Full Text] [Related]
3. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
[TBL] [Abstract][Full Text] [Related]
4. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
Macfarlane DE; Stump DC
Mol Pharmacol; 1982 Nov; 22(3):574-9. PubMed ID: 6296652
[TBL] [Abstract][Full Text] [Related]
5. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
Lenox RH; Ellis J; Van Riper D; Ehrlich YH
Mol Pharmacol; 1985 Jan; 27(1):1-9. PubMed ID: 2981397
[TBL] [Abstract][Full Text] [Related]
6. Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase.
Turner JT; Ray-Prenger C; Bylund DB
Mol Pharmacol; 1985 Nov; 28(5):422-30. PubMed ID: 2865671
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of alpha 2-adrenergic receptors in fetal rat heart: receptors in search of a function.
Lin W; Seidler FJ; McCook EC; Slotkin TA
J Dev Physiol; 1992 Apr; 17(4):183-7. PubMed ID: 1328354
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of forskolin activated adenylate cyclase in hamster adipocyte membranes with prostaglandin E1 and clonidine.
McMahon KK; Schimmel RJ
J Cyclic Nucleotide Res; 1982; 8(1):39-47. PubMed ID: 6890078
[TBL] [Abstract][Full Text] [Related]
9. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
Woodcock EA; Johnston CI
Mol Pharmacol; 1982 Nov; 22(3):589-94. PubMed ID: 6296653
[TBL] [Abstract][Full Text] [Related]
10. Irreversible loss of [3H]forskolin binding sites in human platelets by alpha-haloacetyl analogs of forskolin.
Laurenza A; Morris D; Seamon KB
Mol Pharmacol; 1990 Jan; 37(1):69-74. PubMed ID: 2153911
[TBL] [Abstract][Full Text] [Related]
11. The effects of tetramethylpyrazine on the human platelet alpha 2 adrenergic receptor adenylate cyclase system.
Hui KK; Yu JL; Tse E; Borst S
Res Commun Chem Pathol Pharmacol; 1987 Oct; 58(1):3-14. PubMed ID: 2829329
[TBL] [Abstract][Full Text] [Related]
12. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
13. Alpha-2 adrenoceptors in medullary thick ascending limbs of the rabbit kidney.
Mohuczy-Dominiak D; Garg LC
J Pharmacol Exp Ther; 1993 Jul; 266(1):279-87. PubMed ID: 8392554
[TBL] [Abstract][Full Text] [Related]
14. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
Neubig RR; Gantzos RD; Brasier RS
Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
[TBL] [Abstract][Full Text] [Related]
15. Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits.
Defreyn G; Gachet C; Savi P; Driot F; Cazenave JP; Maffrand JP
Thromb Haemost; 1991 Feb; 65(2):186-90. PubMed ID: 2053105
[TBL] [Abstract][Full Text] [Related]
16. Hormonal inhibition of adenylate cyclase. A crucial role for Mg2+.
Bockaert J; Cantau B; Sebben-Perez M
Mol Pharmacol; 1984 Sep; 26(2):180-6. PubMed ID: 6541292
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
18. Effects of ethanol on adenylate cyclase system in the human platelet.
Saito T; Ozawa H; Tsuchiya F; Ishizawa H; Tabakoff B
Alcohol Alcohol Suppl; 1987; 1():761-5. PubMed ID: 3426758
[TBL] [Abstract][Full Text] [Related]
19. Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na.
Snavely MD; Insel PA
Mol Pharmacol; 1982 Nov; 22(3):532-46. PubMed ID: 6296651
[TBL] [Abstract][Full Text] [Related]
20. Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum.
Nakaki T; Nakadate T; Yamamoto S; Kato R
J Pharmacol Exp Ther; 1982 Mar; 220(3):637-41. PubMed ID: 6121049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
